Abbott India (ABBOTINDIA.NS) Financial Analysis & Valuation | Quarter Chart
Abbott India (ABBOTINDIA.NS)
ABBOTINDIA.NSPrice: $268.96
Fair Value: 🔒
🔒score
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. ... more
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical product... more
Description
Shares
| Market Cap | $5.72B | Exchange | NSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | IN | CEO | Kartik Rajendran |
| IPO Date | 2002-08-12 | CAGR | 0.14% |
| Employees | 3,814 | Website | www.abbott.co.in |
| Div. Yield | 2.55% | Payout Ratio | 0.65% |
| Buy Back Yield | — | Total Yield | 2.55% |
ABBOTINDIA.NS chart loading...
Fundamentals
Technicals
| Enterprise Value | $529.42B | P/E Ratio | 34.4 |
| Forward P/E | 27.83 | PEG Ratio | 4.56 |
| P/S Ratio | 5.68 | P/B Ratio | 8.24 |
| P/CF Ratio | 75.42 | P/FCF Ratio | 77.93 |
| EPS | $7.82 | EPS Growth 1Y | 9.73% |
| EPS Growth 3Y | 63.47% | EPS Growth 5Y | 124.71% |
| Revenue Growth 1Y | 8.15% | Gross Margin | 0.44% |
| Operating Margin | 0.26% | Profit Margin | 0.22% |
| ROE | 0.36% | ROA | 0.24% |
| ROCE | 0.36% | Current Ratio | 2.55 |
| Quick Ratio | 1.91 | Cash Ratio | 1.53 |
| Debt/Equity | 0.04 | Interest Coverage | 72.67 |
| Altman Z Score | 22.87 | Piotroski Score | 3 |